Revvity Inc., US76155R1086

Revvity stock heads into the open after a 3.4% gain

Published on 09/15/2026 at 06:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
At the close on September 14, 2026, Revvity stock finished at USD 128.49 on the NYSE, up 3.4% with an intraday range between roughly USD 124 and USD 129, while the broader market was mixed. Today investors watch follow-up from the Morgan Stanley healthcare conference.
Fotorealistisches Life-Sciences-Labor zeigt Revvity Inc. (ISIN US76155R1086) mit automatisiertem Sequenziergerät und Reagenzien, Illustration mit AI erstellt.

Revvity stock closed at USD 128.49 on the NYSE on September 14, 2026, marking a 3.4% gain for the session. The move left the shares near their recent 52-week high, while broader US equity indices showed a more mixed pattern.

September 14, 2026 in numbers

Revvity Inc. (ISIN US76155R1086, NYSE: RVTY) ended trading on September 14, 2026 at USD 128.49, up 3.4% from the prior close according to NYSE closing data. Intraday, the stock traded roughly between the mid-USD 120s and just under USD 130, keeping the close within that session range and close to the recent 52-week high that one portal placed at about USD 133 per share. A market wrap from an investment research site noted that Revvity shares were trading at USD 128.49 after a 3.4% rise, framing the move as a continuation of recent strength in the name.

For context, major US indices showed a more uneven pattern on September 14, 2026. One market report highlighted that the S&P 500 slipped around 0.5% and the Nasdaq Composite fell about 0.6% on the day, while another summary pointed to a roughly 1% gain for the Dow Jones Industrial Average. These figures underline that Revvity outperformed the technology-heavy Nasdaq Composite and the broader S&P 500 on September 14, 2026, with its 3.4% advance contrasting with those modest index declines.

Conference follow-up in focus today

Today, attention around Revvity is shaped by its participation in the Morgan Stanley 24th Annual Global Healthcare Conference. As Seeking Alpha reported, Revvity presented at the event on September 14, 2026 at 8:30 a.m. EDT, discussing topics such as artificial intelligence, margin trends and growth prospects. A separate conference summary on an investment portal noted that Revvity shares were trading in the mid-USD 120s range and within about 7% of their 52-week high, reinforcing that investors have been rewarding the story around AI integration and profitability. In the absence of a scheduled earnings release today, follow-up commentary from this conference and any analyst reactions may influence how Revvity trades when the US session opens on September 15, 2026.

Disclaimer...
en | US76155R1086 | REVVITY INC. | boerse | 70103232 | bgmi